People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TrialSpark, Inc. | — | Pharmaceuticals | Series D+ | $372.2M | $4.1B | 2024 |
| Via Nova Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $102.9M | 2021 |
Benjamine Liu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamine Liu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alfred Lin | 1 | 10 |
| Michael Moritz | 1 | 7 |
| Ilan Zipkin | 1 | 6 |
| Scott Kupor | 1 | 5 |
| Joseph Jimenez | 1 | 3 |
| Linhao Zhang | 1 | 1 |
| Donald Ganem | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.